Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A0RM6R / Name: Sirona / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Sirona Biochem Corp. Stock

Pros and Cons of Sirona Biochem Corp. in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Sirona Biochem Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Sirona Biochem Corp. - - - - - - -
Satellos Bioscience Inc. -4.150% 2.174% 1.622% 9.302% -32.857% 3.155% -
Larimar Therapeutics Inc. 2.310% 4.000% 38.298% -63.121% -30.108% 30.000% -76.786%
Vaxart Inc. 3.980% -19.843% -6.237% -39.171% -48.771% -89.788% -

Comments

Sell Sirona Biochem Corp.
Show more

Buy Sirona Biochem Corp.
Show more

News

Sirona Biochem Announces Debenture Financing
Sirona Biochem Announces Debenture Financing

VANCOUVER, British Columbia, April 22, 2025 -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) is pleased to announce a non-brokered private placement

Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH

Vancouver, British Columbia – April 22, 2025 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”), a biotechnology company specializing cosmetic ingredients and new drug

Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report
Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report
Microsoft Word - Stonegate Healthcare Publishes Research Report

January 15, 2025 – Vancouver, British Columbia – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is excited to